Comprehensive RNA involved in Cell Death Pathways research database with advanced search and filtering capabilities
| RNA Name | Mechanism of Action | Effect on Cancer | Reference |
|---|---|---|---|
|
CAV1
mRNA |
Caveolin?1 increases IFNGR1, amplifying IFN? signaling to inhibit system Xc? (SLC7A11), thereby promoting lipid peroxidation and ferroptosis. | Overexpression of CAV1 promotes ferroptosis and suppresses breast tumor growth; study used TNBC cells (e.g., MDA?MB?231). | PMID: 39395272 |
External Database SearchDetailed Information
RNA Name:
CAV1
Mechanism of Action:
Caveolin?1 increases IFNGR1, amplifying IFN? signaling to inhibit system Xc? (SLC7A11), thereby promoting lipid peroxidation and ferroptosis.
Effect on Cancer:
Overexpression of CAV1 promotes ferroptosis and suppresses breast tumor growth; study used TNBC cells (e.g., MDA?MB?231).
PMID:
39395272
|
|||
|
VDAC1
mRNA |
VDAC1 oligomerization on mitochondria promotes mitochondrial ROS release required for cysteine-deprivation/RSL3-induced ferroptosis. | In MDA?MB?231/?468 TNBC cells, blocking VDAC1 oligomerization reduces ferroptosis; VDAC1 activity promotes ferroptosis. | PMID: 39521767 |
External Database SearchDetailed Information
RNA Name:
VDAC1
Mechanism of Action:
VDAC1 oligomerization on mitochondria promotes mitochondrial ROS release required for cysteine-deprivation/RSL3-induced ferroptosis.
Effect on Cancer:
In MDA?MB?231/?468 TNBC cells, blocking VDAC1 oligomerization reduces ferroptosis; VDAC1 activity promotes ferroptosis.
PMID:
39521767
|
|||
|
ELAVL1
mRNA |
HuR (ELAVL1) inhibition reduces SLC7A11 and engages ferroptosis among multiple PCDs in breast cancer cells incl. MDA?MB?231 | ELAVL1 activity supports antioxidant defenses; its inhibition promotes ferroptosis and impairs TNBC cell growth (shown in MDA?MB?231) | PMID: 39627778 |
External Database SearchDetailed Information
RNA Name:
ELAVL1
Mechanism of Action:
HuR (ELAVL1) inhibition reduces SLC7A11 and engages ferroptosis among multiple PCDs in breast cancer cells incl. MDA?MB?231
Effect on Cancer:
ELAVL1 activity supports antioxidant defenses; its inhibition promotes ferroptosis and impairs TNBC cell growth (shown in MDA?MB?231)
PMID:
39627778
|
|||
|
PRKAA2
mRNA |
AMPK activation (by CAPE) promotes ROS/lipid peroxidation and downregulates GPX4/ferritin, inducing ferroptosis. | Activation of AMPK triggers ferroptosis and suppresses TNBC growth in cell/xenograft models. | PMID: 39729481 |
External Database SearchDetailed Information
RNA Name:
PRKAA2
Mechanism of Action:
AMPK activation (by CAPE) promotes ROS/lipid peroxidation and downregulates GPX4/ferritin, inducing ferroptosis.
Effect on Cancer:
Activation of AMPK triggers ferroptosis and suppresses TNBC growth in cell/xenograft models.
PMID:
39729481
|
|||
|
PRKAA1
mRNA |
AMPK activation (by CAPE) promotes ROS/lipid peroxidation and downregulates GPX4/ferritin, inducing ferroptosis. | Activation of AMPK triggers ferroptosis and suppresses TNBC growth in cell/xenograft models. | PMID: 39729481 |
External Database SearchDetailed Information
RNA Name:
PRKAA1
Mechanism of Action:
AMPK activation (by CAPE) promotes ROS/lipid peroxidation and downregulates GPX4/ferritin, inducing ferroptosis.
Effect on Cancer:
Activation of AMPK triggers ferroptosis and suppresses TNBC growth in cell/xenograft models.
PMID:
39729481
|
|||
|
EGFR
mRNA |
Cold atmospheric plasma (CAP) modulates EGFR Tyr1068 phosphorylation and potentiates erastin?induced lipid peroxidation/ROS, enhancing ferroptosis. | Sensitizes TNBC cells to ferroptosis and inhibits growth in vitro/in vivo models. | PMID: 39781456 |
External Database SearchDetailed Information
RNA Name:
EGFR
Mechanism of Action:
Cold atmospheric plasma (CAP) modulates EGFR Tyr1068 phosphorylation and potentiates erastin?induced lipid peroxidation/ROS, enhancing ferroptosis.
Effect on Cancer:
Sensitizes TNBC cells to ferroptosis and inhibits growth in vitro/in vivo models.
PMID:
39781456
|
|||
|
SLC38A1
mRNA |
Glutamine transporter SNAT1; GluOC induces SLC38A1 (and SLC7A11) to suppress ferroptosis | Upregulation inhibits ferroptosis and promotes survival of TNBC cells | PMID: 40075587 |
External Database SearchDetailed Information
RNA Name:
SLC38A1
Mechanism of Action:
Glutamine transporter SNAT1; GluOC induces SLC38A1 (and SLC7A11) to suppress ferroptosis
Effect on Cancer:
Upregulation inhibits ferroptosis and promotes survival of TNBC cells
PMID:
40075587
|
|||
|
NEDD4L
mRNA |
E3 ubiquitin ligase that promotes GPX4 ubiquitination and degradation, thereby enabling ferroptosis. | In TNBC cells, resveratrol induces ferroptosis via NEDD4L-mediated GPX4 degradation, increasing lipid peroxidation and cell death. | PMID: 40316059 |
External Database SearchDetailed Information
RNA Name:
NEDD4L
Mechanism of Action:
E3 ubiquitin ligase that promotes GPX4 ubiquitination and degradation, thereby enabling ferroptosis.
Effect on Cancer:
In TNBC cells, resveratrol induces ferroptosis via NEDD4L-mediated GPX4 degradation, increasing lipid peroxidation and cell death.
PMID:
40316059
|
|||
|
HIF1A
mRNA |
Inhibition of the SUCNR1/PI3K/HIF?1? pathway lowers SLC7A11 and promotes ferroptosis. | Blocking HIF?1? signaling induces ferroptosis and suppresses TNBC proliferation/migration in vitro and in vivo. | PMID: 40532859 |
External Database SearchDetailed Information
RNA Name:
HIF1A
Mechanism of Action:
Inhibition of the SUCNR1/PI3K/HIF?1? pathway lowers SLC7A11 and promotes ferroptosis.
Effect on Cancer:
Blocking HIF?1? signaling induces ferroptosis and suppresses TNBC proliferation/migration in vitro and in vivo.
PMID:
40532859
|
|||
|
DHODH
mRNA |
Mitochondrial CoQH2 oxidoreductase that suppresses lipid peroxidation; USP24 deubiquitinates & stabilizes DHODH to block ferroptosis. | Stabilized DHODH limits ferroptosis and supports TNBC growth; targeting USP24�DHODH restores ferroptotic sensitivity. | PMID: 40715045 |
External Database SearchDetailed Information
RNA Name:
DHODH
Mechanism of Action:
Mitochondrial CoQH2 oxidoreductase that suppresses lipid peroxidation; USP24 deubiquitinates & stabilizes DHODH to block ferroptosis.
Effect on Cancer:
Stabilized DHODH limits ferroptosis and supports TNBC growth; targeting USP24�DHODH restores ferroptotic sensitivity.
PMID:
40715045
|
|||